[1]
Morgan, M.R. 2009. Regulation of Innovation Under Follow-On Biologics Legislation: FDA Exclusivity As An Efficient Incentive Mechanism. Science and Technology Law Review. 11, (Nov. 2009). DOI:https://doi.org/10.7916/stlr.v11i0.3846.